3S - Systematic, systemic, and systems biology and toxicology
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
A biological system is more than the sum of its parts - it accomplishes many functions via synergy. Deconstructing the system down to the molecular mechanism level necessitates the complement of reconstructing functions on all levels, i.e., in our conceptualization of biology and its perturbations, our experimental models and computer modelling. Toxicology contains the somewhat arbitrary subclass "systemic toxicities"; however, there is no relevant toxic insult or general disease that is not systemic. At least inflammation and repair are involved that require coordinated signaling mechanisms across the organism. However, the more body components involved, the greater the challenge to reca-pitulate such toxicities using non-animal models. Here, the shortcomings of current systemic testing and the development of alternative approaches are summarized. We argue that we need a systematic approach to integrating existing knowledge as exemplified by systematic reviews and other evidence-based approaches. Such knowledge can guide us in modelling these systems using bioengineering and virtual computer models, i.e., via systems biology or systems toxicology approaches. Experimental multi-organ-on-chip and microphysiological systems (MPS) provide a more physiological view of the organism, facilitating more comprehensive coverage of systemic toxicities, i.e., the perturbation on organism level, without using substitute organisms (animals). The next challenge is to establish disease models, i.e., micropathophysiological systems (MPPS), to expand their utility to encompass biomedicine. Combining computational and experimental systems approaches and the chal-lenges of validating them are discussed. The suggested 3S approach promises to leverage 21st century technology and systematic thinking to achieve a paradigm change in studying systemic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2023) · doi:10.1126/science · Cited by 6,063
1,500 scientists lift the lid on reproducibility
Baker, M. (2016) · Nature · doi:10.1038/533452a · Cited by 4,209
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Forouzanfar, M. H., Alexander, L., Anderson, H. R., Bachman, V. F., Biryukov, S., Brauer, M., Burnett, R., Casey, D., Coates, M. M., Cohen, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00128-2 · Cited by 2,701
Cancer is a preventable disease that requires major lifestyle changes
Anand, P., Kunnumakara, A. B., Sundaram, C., Harikumar, K. B., Tharakan, S. T., Lai, O. S., Sung, B., & Aggarwal, B. B. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9661-9 · Cited by 2,632
The economics of reproducibility in preclinical research
Freedman, L. P., Cockburn, I. M., & Simcoe, T. S. (2015) · PLOS Biology · doi:10.1371/journal.pbio.1002165 · Cited by 1,055 · cited 1×
“A significant portion of irreproducible science could be avoided by using evidence-based approaches (Hartung, 2013; Freedman et al., 2015).”
BackgroundMulti-tissue interactions in an integrated three-tissue organ-on-a-chip platform
Skardal, A., Murphy, S. V., Devarasetty, M., Mead, I., Kang, H.-W., Seol, Y.-J., Shrike Zhang, Y., Shin, S.-R., Zhao, L., Aleman, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-08879-x · Cited by 623 · cited 1×
“Three decades of experience have laid the foundation to broaden this concept to MPS in the context of their use in the life sciences and especially in drug development (Abaci and Shuler, 2015; Ewart et al., 2017; Skardal et al., 2016, 2017).”
BackgroundSelf-citationOrganoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling
Skardal, A., Shupe, T., & Atala, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.003 · Cited by 512 · cited 3×
“…multiplexed endpoints (Kleinstreuer et al., 2014) and organotypic cultures reproducing organ architecture and functionalities (microphysiological systems, MPS) (Marx et al., 2016), now even moving to multi-organ models of a human-on-chip / body-on-chip (Skardal et al., 2016; Watson et al., 2017).”
BackgroundAdverse outcome pathways: opportunities, limitations and open questions
Leist, M., Ghallab, A., Graepel, R., Marchan, R., Hassan, R., Bennekou, S. H., Limonciel, A., Vinken, M., Schildknecht, S., Waldmann, T., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-2045-3 · Cited by 394
Self-citationCoecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371 · cited 1×
“The Good Cell Culture Practice (GCCP) movement initiated by one of the authors in 1996 led to the first guidance of its kind (Coecke et al., 2005) under the auspices of ECVAM.”
MethodDrug research: myths, hype and reality
Kubinyi, H. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1156 · Cited by 348
A Modular Approach to the ECVAM Principles on Test Validity
Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., et al. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200503 · Cited by 341 · cited 2×
“• “Performance standards”: The concept of a performance standard for alternative methods was introduced in the Modular Approach in 2004 (Hartung et al., 2004) and incorporated into OECD validation guidance from 2005 (OECD, 2005).”
MethodSelf-citationMarx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
Reproducibility of preclinical animal research improves with heterogeneity of study samples
Voelkl, B., Vogt, L., Sena, E. S., & Würbel, H. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2003693 · Cited by 262
Judson, R., Houck, K., Martin, M., Richard, A. M., Knudsen, T. B., Shah, I., Little, S., Wambaugh, J., Woodrow Setzer, R., Kothya, P., et al. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw092 · Cited by 232
Self-citationPhenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms
Kleinstreuer, N. C., Yang, J., Berg, E. L., Knudsen, T. B., Richard, A. M., Martin, M. T., Reif, D. M., Judson, R. S., Polokoff, M., Dix, D. J., et al. (2014) · Nature Biotechnology · doi:10.1038/nbt.2914 · Cited by 211 · cited 2×
“Cell culture is starting to embrace this with the advent of complex co-cultures with multiplexed endpoints (Kleinstreuer et al., 2014) and organotypic cultures reproducing organ architecture and functionalities (microphysiological systems, MPS) (Marx et al., 2016), now even moving to multi-organ…”
BackgroundSelf-citationIs animal research sufficiently evidence based to be a cornerstone of biomedical research?
Pound, P., & Bracken, M. B. (2014) · BMJ · doi:10.1136/bmj.g3387 · Cited by 207
Good Cell Culture Practice for stem cells and stem-cell-derived models
Pamies, D. (2016) · ALTEX · doi:10.14573/altex.1607121 · Cited by 160 · cited 2×
“The concomitant emerging availability of human stem cells that can be used to produce high-quality organoids further adds to this revolutionary change (Suter-Dick et al., 2015), as shown recently for the BrainSphere organoid model (Pamies et al., 2017a, 2018a).”
BackgroundInfluentialPamies, D. (2018) · ALTEX · doi:10.14573/altex.1710081 · Cited by 127 · cited 2×
“The concomitant emerging availability of human stem cells that can be used to produce high-quality organoids further adds to this revolutionary change (Suter-Dick et al., 2015), as shown recently for the BrainSphere organoid model (Pamies et al., 2017a, 2018a).”
BackgroundInfluentialValidation and quality control of replacement alternatives - current status and future challenges
Leist, M., Hasiwa, N., Daneshian, M., & Hartung, T. (2012) · Toxicology Research · doi:10.1039/c2tx20011b · Cited by 100 · cited 1×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript meet the needs of stakeholders (Hartung, 2007; Leist et al., 2012).”
BackgroundSelf-citationTen questions about systems biology
Joyner, M. J., & Pedersen, B. K. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2010.201509 · Cited by 93
A primer on systematic reviews in toxicology
Hoffmann, S., de Vries, R. B. M., Stephens, M. L., Beck, N. B., Dirven, H. A. A. M., Fowle, J. R., Goodman, J. E., Hartung, T., Kimber, I., Lalu, M. M., et al. (2017) · Archives of Toxicology · doi:10.1007/s00204-017-1980-3 · Cited by 85
Self-citationAlden, C. L., Lynn, A., Bourdeau, A., Morton, D., Sistare, F. D., Kadambi, V. J., & Silverman, L. (2011) · Veterinary Pathology · doi:10.1177/0300985811400445 · Cited by 69 · cited 1×
“Its adequacy to predict cancer risk in humans, however, is the subject of considerable debate (Gottmann et al., 2001; Alden et al., 2011; Knight et al., 2006a,b; Paules et al., 2011) (Tab.”
BackgroundBouhifd, M. (2015) · ALTEX · doi:10.14573/altex.1502091 · Cited by 69
Good cell culture practices & in vitro toxicology
Eskes, C., Boström, A.-C., Bowe, G., Coecke, S., Hartung, T., Hendriks, G., Pamies, D., Piton, A., & Rovida, C. (2017) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.04.022 · Cited by 52
Self-citationKholodenko, B. N. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.014 · Cited by 49
Cited by
New approach methodologies in human regulatory toxicology – Not if, but how and when!
Schmeisser, S., Miccoli, A., von Bergen, M., Berggren, E., Braeuning, A., Busch, W., Desaintes, C., Gourmelon, A., Grafström, R., Harrill, J., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108082 · Cited by 380
Luechtefeld, T., Marsh, D., Rowlands, C., & Hartung, T. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy152 · Cited by 327
Animal testing and its alternatives—the most important omics is economics
Meigs, L. (2018) · ALTEX · doi:10.14573/altex.1807041 · Cited by 184
Microglia increase inflammatory responses in iPSC-derived human BrainSpheres
Abreu, C. M., Gama, L., Krasemann, S., Chesnut, M., Odwin-Dacosta, S., Hogberg, H. T., Hartung, T., & Pamies, D. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02766 · Cited by 123
Ainslie, G. R., Davis, M., Ewart, L., Lieberman, L. A., Rowlands, D. J., Thorley, A. J., Yoder, G., & Ryan, A. M. (2019) · Lab on a Chip · doi:10.1039/c9lc00492k · Cited by 65
Metadata
- Authors
- Smirnova, L.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2018
- Volume
- 35
- Issue
- 2
- Pages
- 139-162
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2800495173
- Cited by
- 72
- References
- 26
- FWCI
- 11.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.